These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10834619)

  • 1. Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington's disease.
    Mittoux V; Joseph JM; Conde F; Palfi S; Dautry C; Poyot T; Bloch J; Deglon N; Ouary S; Nimchinsky EA; Brouillet E; Hof PR; Peschanski M; Aebischer P; Hantraye P
    Hum Gene Ther; 2000 May; 11(8):1177-87. PubMed ID: 10834619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease.
    Emerich DF; Winn SR; Hantraye PM; Peschanski M; Chen EY; Chu Y; McDermott P; Baetge EE; Kordower JH
    Nature; 1997 Mar; 386(6623):395-9. PubMed ID: 9121555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study.
    Bloch J; Bachoud-Lévi AC; Déglon N; Lefaucheur JP; Winkel L; Palfi S; Nguyen JP; Bourdet C; Gaura V; Remy P; Brugières P; Boisse MF; Baudic S; Cesaro P; Hantraye P; Aebischer P; Peschanski M
    Hum Gene Ther; 2004 Oct; 15(10):968-75. PubMed ID: 15585112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF.
    Bachoud-Lévi AC; Déglon N; Nguyen JP; Bloch J; Bourdet C; Winkel L; Rémy P; Goddard M; Lefaucheur JP; Brugières P; Baudic S; Cesaro P; Peschanski M; Aebischer P
    Hum Gene Ther; 2000 Aug; 11(12):1723-9. PubMed ID: 10954906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular delivery of CNTF but not NT-4/5 prevents degeneration of striatal neurons in a rodent model of Huntington's disease.
    Emerich DF; Bruhn S; Chu Y; Kordower JH
    Cell Transplant; 1998; 7(2):213-25. PubMed ID: 9588602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticostriatopallidal neuroprotection by adenovirus-mediated ciliary neurotrophic factor gene transfer in a rat model of progressive striatal degeneration.
    Mittoux V; Ouary S; Monville C; Lisovoski F; Poyot T; Conde F; Escartin C; Robichon R; Brouillet E; Peschanski M; Hantraye P
    J Neurosci; 2002 Jun; 22(11):4478-86. PubMed ID: 12040055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent neuroprotective effect of ciliary neurotrophic factor delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease.
    Régulier E; Pereira de Almeida L; Sommer B; Aebischer P; Déglon N
    Hum Gene Ther; 2002 Nov; 13(16):1981-90. PubMed ID: 12427308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained striatal ciliary neurotrophic factor expression negatively affects behavior and gene expression in normal and R6/1 mice.
    Denovan-Wright EM; Attis M; Rodriguez-Lebron E; Mandel RJ
    J Neurosci Res; 2008 Jun; 86(8):1748-57. PubMed ID: 18293418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular delivery of human CNTF prevents motor and cognitive dysfunction in a rodent model of Huntington's disease.
    Emerich DF; Cain CK; Greco C; Saydoff JA; Hu ZY; Liu H; Lindner MD
    Cell Transplant; 1997; 6(3):249-66. PubMed ID: 9171158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term lentiviral-mediated expression of ciliary neurotrophic factor in the striatum of Huntington's disease transgenic mice.
    Zala D; Bensadoun JC; Pereira de Almeida L; Leavitt BR; Gutekunst CA; Aebischer P; Hayden MR; Déglon N
    Exp Neurol; 2004 Jan; 185(1):26-35. PubMed ID: 14697316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of encapsulated CNTF-producing cells in a rodent model of Huntington's disease are dependent on the proximity of the implant to the lesioned striatum.
    Emerich DF; Winn SR
    Cell Transplant; 2004; 13(3):253-9. PubMed ID: 15191163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington's disease.
    de Almeida LP; Zala D; Aebischer P; Déglon N
    Neurobiol Dis; 2001 Jun; 8(3):433-46. PubMed ID: 11442352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy for Huntington's disease.
    Ramaswamy S; Kordower JH
    Neurobiol Dis; 2012 Nov; 48(2):243-54. PubMed ID: 22222669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent neurochemical and functional protection afforded by encapsulated CNTF-producing cells.
    Emerich DF
    Cell Transplant; 2004; 13(7-8):839-44. PubMed ID: 15690987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington's disease.
    Lee WT; Chang C
    Prog Neurobiol; 2004 Feb; 72(2):87-110. PubMed ID: 15063527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracompartmental delivery of CNTF as therapy for Huntington's disease and retinitis pigmentosa.
    Emerich DF; Thanos CG
    Curr Gene Ther; 2006 Feb; 6(1):147-59. PubMed ID: 16475952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between BDNF expression in major striatal afferents, striatum morphology and motor behavior in the R6/2 mouse model of Huntington's disease.
    Samadi P; Boutet A; Rymar VV; Rawal K; Maheux J; Kvann JC; Tomaszewski M; Beaubien F; Cloutier JF; Levesque D; Sadikot AF
    Genes Brain Behav; 2013 Feb; 12(1):108-24. PubMed ID: 23006318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.
    Lastres-Becker I; Hansen HH; Berrendero F; De Miguel R; Pérez-Rosado A; Manzanares J; Ramos JA; Fernández-Ruiz J
    Synapse; 2002 Apr; 44(1):23-35. PubMed ID: 11842443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington's disease, as demonstrated by adenoviral gene transfer.
    Bemelmans AP; Horellou P; Pradier L; Brunet I; Colin P; Mallet J
    Hum Gene Ther; 1999 Dec; 10(18):2987-97. PubMed ID: 10609659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo delivery of GDNF maintains motor function and prevents neuronal loss in a transgenic mouse model of Huntington's disease.
    Ebert AD; Barber AE; Heins BM; Svendsen CN
    Exp Neurol; 2010 Jul; 224(1):155-62. PubMed ID: 20227407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.